Shimada, Yoshihisa
Kudo, Yujin
Maehara, Sachio
Fukuta, Kentaro
Masuno, Ryuhei
Park, Jinho
Ikeda, Norihiko
Funding for this research was provided by:
Fujifilm Corporation
Article History
Received: 17 September 2022
Accepted: 16 January 2023
First Online: 19 January 2023
Competing interests
: Dr. Shimada, Dr. Kudo, Dr. Maehara, Dr. Masuno, Dr. Fukuta, and Dr. Park have no conflicts to disclose. Dr. Ikeda reports grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Chugai Pharma, grants and personal fees from Eli Lilly, grants and personal fees from MSD, grants and personal fees from Nihon Medi-Physics, grants and personal fees from Ono Pharmaceutical, grants and personal fees from Pfizer, grants and personal fees from Taiho Pharmaceutical, grants and personal fees from Teijin, and personal fees from Bristol-Meyers Squibb Japan outside the submitted work.